Mitsu Chem Plast Limited Q3 FY26: 73% EBITDA Growth Drives Strong Performance
Mitsu Chem Plast Limited reported outstanding Q3 FY26 financial performance with EBITDA rising 73.35% to ₹954.45 lakhs and net profit surging 217.03% to ₹470.63 lakhs year-on-year. The company completed capacity expansion of 655 MT and announced additional 900 MT expansion in Unit 4, targeting ₹1,000 crores revenue by FY 2028 through strategic focus on niche healthcare products and export growth across 17 countries.

*this image is generated using AI for illustrative purposes only.
Mitsu Chem Plast Limited announced strong Q3 FY26 financial results, demonstrating significant improvement in profitability metrics. The polymer-based molded products manufacturer reported robust growth across key financial parameters, with EBITDA rising 73.35% and net profit surging 217.03% compared to the same quarter last year.
Financial Performance Highlights
The company's Q3 FY26 performance showed substantial improvement in both revenue and profitability metrics. Total income grew 6.92% to ₹8,608.85 lakhs from ₹8,051.78 lakhs in Q3 FY25, while EBITDA expanded dramatically to ₹954.45 lakhs from ₹550.67 lakhs, representing a 73.35% year-on-year increase.
| Particulars (₹ Lakhs): | Q3 FY26 | Q3 FY25 | YoY Growth |
|---|---|---|---|
| Total Income: | 8,608.85 | 8,051.78 | ↑ 6.92% |
| EBITDA: | 954.45 | 550.67 | ↑ 73.35% |
| EBITDA Margin (%): | 11.10% | 6.84% | ↑ 426 Bps |
| Net Profit: | 470.63 | 148.49 | ↑ 217.03% |
| Net Profit Margin (%): | 5.47% | 1.85% | ↑ 363 Bps |
| EPS (₹): | 3.47 | 1.09 | ↑ 218.35% |
Nine-Month Performance
For the nine-month period ending December 31, 2025, Mitsu Chem Plast Limited maintained strong momentum with total income reaching ₹26,405.09 lakhs, up 8.94% from ₹24,237.28 lakhs in 9M FY25. EBITDA for the period grew 35.71% to ₹2,043.58 lakhs, while net profit more than doubled to ₹790.13 lakhs from ₹370.91 lakhs.
| Particulars (₹ Lakhs): | 9M FY26 | 9M FY25 | YoY Growth |
|---|---|---|---|
| Total Income: | 26,405.09 | 24,237.28 | ↑ 8.94% |
| EBITDA: | 2,043.58 | 1,505.82 | ↑ 35.71% |
| EBITDA Margin (%): | 7.75% | 6.23% | ↑ 152 Bps |
| Net Profit: | 790.13 | 370.91 | ↑ 113.03% |
| Net Profit Margin (%): | 3.00% | 1.53% | ↑ 146 Bps |
| EPS (₹): | 5.82 | 2.77 | ↑ 110.11% |
Management Insights and Growth Strategy
During the earnings conference call held on February 02, 2026, Managing Director Manish Dedhia outlined the company's strategic focus on profitable growth through operational excellence and diversification. The management emphasized their target of achieving ₹1,000 crores in annual revenue by FY 2028, supported by capacity expansion and enhanced product mix.
| Strategic Parameter: | Details |
|---|---|
| Revenue Target: | ₹1,000 crores by FY 2028 |
| Current Capacity Utilization: | 65% |
| Niche Product Mix: | 16% of total sales |
| Export Markets: | 17 countries |
| EBITDA Margin Target: | 8-10% sustainable range |
The company's niche products, including healthcare furniture components under the Furnastra brand, command 5-7% higher margins compared to commodity products. Management expects to maintain the niche product contribution at 15-20% while scaling overall operations.
Capacity Expansion Initiative
The company completed a significant capacity expansion during the quarter, adding approximately 655 MT per annum to take total manufacturing capacity to over 29,000 MT per annum. This expansion was commissioned by November 2025 and was funded entirely through internal accruals. Additionally, the company announced Unit 4 expansion in January 2026, adding another 900 metric tons of capacity.
| Parameter: | Details |
|---|---|
| Q3 Capacity Addition: | ~655 MT per annum |
| January 2026 Addition: | 900 MT per annum |
| Total Current Capacity: | ~29,000+ MT per annum |
| Funding Source: | Internal accruals |
| Peak Revenue Potential: | ₹450 crores (current capacity) |
Export Growth and Market Expansion
The company's export business showed steady progress, currently contributing 2.5% of total revenue across 17 countries, primarily in Europe, Canada, and Gulf regions. The export focus remains on niche healthcare furniture components, which offer better margins than domestic sales. Management expressed confidence in significant export growth following successful product approvals in international markets.
Company Overview
Mitsu Chem Plast Limited operates as a certified manufacturer of polymer-based molded products, serving diverse industries including Industrial Packaging Solutions, Healthcare Products, Infrastructure Products, and Emergency Handling Solutions. The company operates three manufacturing facilities in Maharashtra with over 51 blow molding and 20 injection molding machines, primarily catering to Original Equipment Manufacturers across chemical, pharmaceutical, dyes, agrochemical, disinfectants, diagnostic, hospital, and infrastructure furniture sectors.
Historical Stock Returns for Mitsu Chem Plast
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.05% | -4.08% | +2.99% | -1.41% | +11.61% | +9.40% |

































